🏛️ Verified NIH Record • Updated 2025-10-22
Detection of Genetic Markers of Lung Cancer (NCT00280202)
Detection of Genetic Markers of Lung Cancer Initiation and Progression
🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: University of Pittsburgh
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this research study is to determine the genetic changes and immunologic changes that are involved in the development and progression of bronchogenic lung cancer.
Who can join: Review the eligibility criteria below.
Location: Hillman Cancer Center — Pittsburgh, Pennsylvania
Age range: 18 Years
🧪 Interventions in This Study
- Biopsy of the major carinal area (PROCEDURE)
- Biopsy of abnormal & suspicious areas of the bronchial tree (PROCEDURE)
- Evaluation of the tumor for DNA mutations (PROCEDURE)
- Bronchoalveolar Lavage (BAL) for cytokine analysis (PROCEDURE)
- Correlation of flow cytometric & RT PCR for TNM stage (PROCEDURE)
- Analysis of lymph nodes (PROCEDURE)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Hillman Cancer Center — Pittsburgh, Pennsylvania
📞 Contact the Study Coordinator
Phone: (412) 647-8583
Email: wardj@upmc.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Lung Cancer
- Implementation Strategies for Monitoring Adherence in Real Time — Philadelphia, Pennsylvania
- Early Detection of Lung Cancer — Nashville, Tennessee
- Improving Utilization of Lung Cancer Screening in Underserved PA Populations — Allentown, Pennsylvania
- Effect of Pulmonary Rehabilitation on Surgical Outcomes in the Cancer Setting — Houston, Texas
- Testing the Engaged Approach to Lung Cancer Screening — Denver, Colorado
- Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung Cancer — Boston, Massachusetts
Explore by condition: All Lung Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.